Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 15 citing Ahrén: Neuropeptides and the regulation of islet function. (0.11 sec) 

microRNAs and the regulation of glucose and lipid metabolism


MN Poy, M Spranger, M Stoffel - Diabetes Obes Metab, 2007 - interscience.wiley.com
Over recent years, metabolic disorders such as type 2 diabetes have finally
become recognized as a major challenge to global health. The attention of
scientists therefore has to focus on improving our understanding of the ...
Cited by 24 - Related articles - All 2 versions

Glucagon receptor knockout mice display increased insulin sensitivity and impaired β-cell …

- diabetesjournals.org
H Sørensen, MS Winzell, CL Brand, K … - Diabetes, 2006 - Am Diabetes Assoc
In previous studies, glucagon receptor knockout mice (Gcgr −/− ) display
reduced blood glucose and increased glucose tolerance, with hyperglucagonemia
and increased levels of glucagon-like peptide (GLP)-1. However, the role of ...
Cited by 15 - Related articles - BL Direct - All 3 versions

Role of VIP and PACAP in islet function


MS Winzell, B Ahrén - Peptides, 2007 - Elsevier
Vasoactive intestinal polypeptide (VIP) and pituitary adenylate
cyclase-activating polypeptide (PACAP) are two closely related neuropeptides
that are expressed in islets and in islet parasympathetic nerves. Both ...
Cited by 11 - Related articles - All 2 versions

Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice

- endojournals.org
Y Imai, HR Patel, EJ Hawkins, NM Doliba, FM … - Endocrinology, 2007 - Endocrine Soc
Neuropeptide Y (NPY), whose role in appetite regulation is well known, is also
expressed in pancreatic islets. Although previous studies indicated that
application of NPY to pancreatic islets inhibits insulin secretion, its ...
Cited by 7 - Related articles - BL Direct - All 3 versions

VMAT2 gene expression and function as it applies to imaging β-cell mass


PE Harris, C Ferrara, P Barba, T Polito, M … - Journal of Molecular Medicine, 2008 - Springer
Page 1. REVIEW VMAT2 gene expression and function as it applies to imaging
β-cell mass Paul E. Harris & Caterina Ferrara & Pasquale Barba & ...
Cited by 4 - Related articles - BL Direct - All 2 versions

Sympathetic modulation by levodopa reduces vascular risk factors in Parkinson disease


G Scigliano, G Ronchetti, F Girotti, M Musicco - Parkinsonism and Related Disorders, 2009 - Elsevier
On admission levodopa-treated patients had significantly lower plasma levels of
triglycerides, total cholesterol and lipids, and lower frequency of diabetes and
hypertension than untreated patients. Mean body mass index, resting blood ...
Cited by 3 - Related articles - All 6 versions

Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine …


B Ahrén - Annals of the New York Academy of Sciences, 2008 - interscience.wiley.com
In the pancreatic islets, pituitary adenylate cyclase-activating polypeptide
(PACAP) is expressed in β cells and autonomic nerve terminals; the majority of
these nerve terminals are parasympathetic. PACAP binds to three types of G ...
Cited by 2 - Related articles - All 4 versions

Levodopa reduces risk factors for vascular disease in parkinsonian patients


G Scigliano, G Ronchetti, F Girotti, M Musicco - Journal of Neurology, 2008 - Springer
Sirs: Levodopa is still the best anti- parkinson drug available but is suspected
of increasing the risk of vascular disorders because it in- duces
hyperhomocysteinemia [1] − an independent risk factor for cardiovascular ...
Cited by 2 - Related articles - All 2 versions

Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse …

- endocrinology-journals.org
AM O'Carroll, GM Howell, EM Roberts, SJ … - Journal of Endocrinology, 2008 - Soc Endocrinology
Arginine vasopressin (AVP) and corticotropin-releasing hormone (CRH) have both
been implicated in modulating insulin secretion from pancreatic β-cells. In the
present study, we investigated the insulin-secreting activities of AVP and ...
Cited by 1 - Related articles - BL Direct - All 10 versions

Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from …


AM O'Carroll, GM Howell, EM Roberts, SJ … - The Journal of Endocrinology, 2008 - ukpmc.ac.uk
Arginine vasopressin (AVP) and corticotropin-releasing hormone (CRH) have both
been implicated in modulating insulin secretion from pancreatic β-cells. In the
present study, we investigated the insulin-secreting activities of AVP and ...
Related articles - All 2 versions


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google